Clinical trials
Recruiting Phase 1 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fujian Medical University | 1 |
| Henry Ford Health System | 1 |
| Leslie Kean | 1 |
| Sawa Ito, MD | 1 |
| Tr1X, Inc. | 1 |
| University of Kansas Medical Center | 1 |
| University of Wisconsin, Madison | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 10 |
| Myelodysplastic Syndromes | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Hematologic Neoplasms | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Myeloproliferative Disorders | 1 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.